Detalles de la búsqueda
1.
Sustained peripheral depletion of amyloid-ß with a novel form of neprilysin does not affect central levels of amyloid-ß.
Brain
; 137(Pt 2): 553-64, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24259408
2.
Improved CRISPR genome editing using small highly active and specific engineered RNA-guided nucleases.
Nat Commun
; 12(1): 4219, 2021 07 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34244505
3.
Targeted inhibition of activated protein C by a non-active-site inhibitory antibody to treat hemophilia.
Nat Commun
; 11(1): 2992, 2020 06 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32532974
4.
Addendum to: Improved CRISPR genome editing using small highly active and specific engineered RNA-guided nucleases.
Nat Commun
; 14(1): 3503, 2023 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37311765
5.
Preclinical Antitumor Efficacy of BAY 1129980-a Novel Auristatin-Based Anti-C4.4A (LYPD3) Antibody-Drug Conjugate for the Treatment of Non-Small Cell Lung Cancer.
Mol Cancer Ther
; 16(5): 893-904, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28292941
6.
Purine nucleoside phosphorylase from Cellulomonas sp.: physicochemical properties and binding of substrates determined by ligand-dependent enhancement of enzyme intrinsic fluorescence, and by protective effects of ligands on thermal inactivation of the enzyme.
Biochim Biophys Acta
; 1597(2): 320-34, 2002 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-12044910
7.
Engineering neprilysin activity and specificity to create a novel therapeutic for Alzheimer's disease.
PLoS One
; 9(8): e104001, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25089527
Resultados
1 -
7
de 7
1
Próxima >
>>